about
Botulinum toxin type B for cervical dystoniaConsiderations on patient-related outcomes with the use of botulinum toxins: is switching products safe?Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical PracticeGlobal Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain SyndromeBotulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis.Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.Selective neurolysis in post-paralytic facial nerve syndrome (PFS).Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disordersNeutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysis.Pharmacokinetics and pharmacodynamics of incobotulinumtoxinA influencing the clinical efficacy in post-stroke spasticity.Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.A new paradigm for the management of essential vocal tremor with botulinum toxin.Botulinum Toxin in Aesthetic Medicine: Myths and Realities.Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity.OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.Delayed Hypersensitivity Reaction to OnabotulinumtoxinA
P2860
Q24185766-18138441-ED25-4364-A83F-3D8CA59BAA92Q26766284-3F6B01D4-551C-4B04-8F99-C6EDDD1AF7D4Q26766728-80A53411-9020-4B5C-9F8E-0BB9EBF6F48BQ30835378-EF72F64A-77BB-45FB-819F-17C7A9FAAC08Q33696600-E1F02F4A-A081-4E5D-8AC0-20FFDE6947F8Q33696624-8A7583ED-91D5-480A-8F6F-80A3C3F0EC6AQ35542237-3905193C-F74B-4B68-985B-80C5E93427C1Q36226899-9E61C3B9-66D2-4ECC-B29B-DBDDB6509260Q37496473-01046359-56A8-4B2E-ACA5-792BEDF35243Q37662597-E7FF1D38-C337-4F54-B8D4-C3317535D94DQ37717924-99CBD4C6-0F79-4B61-89FF-1126604955C4Q38080776-04012740-E705-4560-85D6-EF0B2BEC103FQ38218378-E19000E1-C531-4AEF-8B08-8D3221881B59Q38432422-7CB03430-79AA-44BF-A892-BDE51E5C757AQ38607345-2F8DDB7A-4DC8-4F93-ACDF-4CB698485483Q38735879-D940CBE9-5320-4510-ADB8-15E19D14DD34Q38990991-2D37E760-5B13-4F6C-B5D1-E84BAFF6E8D3Q39446871-6920CA28-CC3C-409B-95FE-5B0041C80BD9Q43185582-99433B4F-781F-4227-A27B-C0FE7487E1CCQ44968846-478CD399-7E26-4A66-B174-80AA2AB2D27AQ46135634-028D4986-D450-4FF9-9760-7EFBE581FA0EQ47671772-D6C1726E-F179-48AA-8E82-F08174C68AD8Q48075632-3E881CA8-2404-44AB-9CEF-7A92432C4C68Q48418075-C016FC9D-DE5B-4D20-9151-D6F5932B80DDQ58575613-71C0857B-0CD2-4F87-8852-37D9565FE75F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinical relevance of botulinum toxin immunogenicity
@ast
Clinical relevance of botulinum toxin immunogenicity
@en
Clinical relevance of botulinum toxin immunogenicity
@nl
type
label
Clinical relevance of botulinum toxin immunogenicity
@ast
Clinical relevance of botulinum toxin immunogenicity
@en
Clinical relevance of botulinum toxin immunogenicity
@nl
prefLabel
Clinical relevance of botulinum toxin immunogenicity
@ast
Clinical relevance of botulinum toxin immunogenicity
@en
Clinical relevance of botulinum toxin immunogenicity
@nl
P2860
P921
P1433
P1476
Clinical relevance of botulinum toxin immunogenicity
@en
P2093
Reiner Benecke
P2860
P356
10.2165/11599840-000000000-00000
P407
P577
2012-04-01T00:00:00Z
P5875
P6179
1007613743